Loading company…
TRACON Pharmaceuticals develops targeted biologic therapies for cancer.
TRACON Pharmaceuticals develops and commercializes cancer therapies, including investigational treatments targeting specific genetic markers or tumor types. It serves healthcare providers and patients in the US and selected international markets. Founded in 2006, the company is headquartered in San Diego, US. It raised USD 36 mn in an IPO in January 2015.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in